A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats

References

• Bajgar, J. (2004). Organophosphate/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• Bajgar, J. (2005). Complex view on poisoning with nerve agents and organophosphates. Acta Med (Hradec Kralove) 48:3–21.
   PubMedGoogle Scholar
• Carpentier, P., Delamanche, L. S., Le Bert, M., Blanchet, G., Bouchard, C. (1990). Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology 11:493–508.
   PubMed Web of Science ®Google Scholar
• Clement, J. G. (1992). Central activity of acetylcholinesterase oxime reactivators. Toxicol Appl Pharmacol 112:104–109.
   PubMed Web of Science ®Google Scholar
• Clement, J. G., Shiloff, J. D., Gennings, C. (1987). Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice. Arch Toxicol 61:70–75.
   PubMed Web of Science ®Google Scholar
• Dawson, R. M. (1994). Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14:317–331.
   PubMed Web of Science ®Google Scholar
• Frantik, E., Hornychova, M. (1995). Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19–25.
   Google Scholar
• Grange-Messent, V., Bouchard, C., Jamme, M., Lallement, G., Foguin, A., Carpentier, P. (1999). Seizure-related opening of the blood-brain barrier produced by the anticholinesterase compound, soman: new ultrastructural observations. Cell Mol Biol 45:1–14.
   PubMed Web of Science ®Google Scholar
• Jokanovic, M., Prostran, M. (2009). Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 16:2177–2188.
   PubMed Web of Science ®Google Scholar
• Kassa, J. (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• Kassa, J., Karasova, J. (2007). A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats. Drug Chem Toxicol 30:117–131.
   PubMed Web of Science ®Google Scholar
• Kassa, J., Karasova, J., Musilek, K., Kuca, K. (2008). An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 243:311–316.
   PubMed Web of Science ®Google Scholar
• Kassa, J., Karasova, J., Vasina, L., Bajgar, J., Kuca, J., Musilek, K. (2009). A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats. Drug Chem Toxicol 32:128–138.
   PubMed Web of Science ®Google Scholar
• Kassa, J., Kuca, K., Bartosova, L., Kunesova, G. (2007). The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 11:267–283.
   Web of Science ®Google Scholar
• Kovacevic, V., Maksimovic, M., Deljac, V., Binenfeld, Z. (1991). Protective effects of mixture of oximes in poisoning by nerve chemical warfare agents. Acta Pharm Jugoslav 41:75–78.
   Google Scholar
• Kovacevic, V., Maksimovic, M., Pantelic, D., Vojvodic, V., Binenfeld, Z. (1989). Protective and reactivating effects of HI-6 PAM-2 mixture in rats poisoned with nerve chemical warfare agents. Acta Pharm Jugoslav 39:161–165.
   Google Scholar
• Kovarik, Z., Calic, M., Sinko, G., Bosak, A., Berend, S., Vrdoljak, A., et al. (2008). Oximes: reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem Biol Interact 175:173–179.
   PubMed Web of Science ®Google Scholar
• Kovarik, Z., Lucic Vrdoljak, A., Berend, S., Catalinic, M., Kuca, K., Musilek, K., et al. (2009). Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 60:19–26.
   PubMed Web of Science ®Google Scholar
• Kuca, K., Musilek, K., Jun, D., Pohanka, M., Zdarova Karasova, J., Novotny, L., et al. (2009). Could oxime HI-6 really be considered as “broad-spectrum” antidote? J Appl Biomed 7:143–149.
   Web of Science ®Google Scholar
• Laufer, R., Kalasz, H., Musilek, K., Szegi, P., Darvas, F., Kuca, K., et al. (2010). Synthesis, antidotal effects and HPLC behavior of some novel pyridinium aldoximes. Curr Org Chem 14:447–456.
   Web of Science ®Google Scholar
• Lotti, M. (2000). Organophosphorus compounds. In: Spencer, P. S., Schaumburg, H. H. (Eds.), Experimental and clinical neurotoxicology (pp 898–925 ). New York: Oxford University Press.
   Google Scholar
• Lundy, P. M., Raveh, L., Amitai, G. (2006). Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol Rev 25:231–243.
   PubMedGoogle Scholar
• Luo, C. Y., Tong, M., Chilukuri, N., Brecht, K., Maxwell, D. M., Saxena, A. (2007). An in vitro comparative study on the reactivation of nerve agent–inhibited guinea-pig and human acetylcholinesterases by oximes. Biochemistry 48:11771–11779.
   Google Scholar
• Maksimovic, M., Kovacevic, V. (1989). Protective and reactivating effects of HI-6-toxogonin mixture in rats and guinea-pigs poisoned by nerve agents. Acta Pharm Jugoslav 39:27–33.
   Google Scholar
• Marrs, T. C., Rice, P., Vale, J. A. (2006). The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 25:297–323.
   PubMedGoogle Scholar
• McDonough, J. H., Jr., Shih, T-M. (1997). Neuropharmacological modulation of nerve agent–induced seizure and neuropathology. Neurosci Biobehav Rev 21:559–579.
   PubMed Web of Science ®Google Scholar
• Moser, V. C., Tilson, H., McPhail, R. C., Becking, G. C., Cuomo, V., Frantik, E., et al. (1997). The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 18:929–938.
   PubMed Web of Science ®Google Scholar
• Musilek, K., Holas, O., Kuca, K., Jun, D., Dohnal, V., Opletalova, V., et al. (2008). Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J Enz Inhib Med Chem 23:70–76.
   PubMed Web of Science ®Google Scholar
• Musilek, K., Jun, D., Cabal, J., Kassa, J., Gunn-Moore, F., Kuca, K. (2007). Design of a potent reactivator of tabun-inhibited acetylcholinesterase—synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). J Med Chem 50:5514–5518.
   PubMed Web of Science ®Google Scholar
• Roth, Z., Josifko, M., Maly, V., Trcka, V. (1962). Statistical methods in experimental medicine (in Czech). Prague: SZN.
   Google Scholar
• Szinicz, L., Worek, F., Thiermann, H., Kehe, K., Eckert, S., Eyer, P. (2007). Development of antidotes: problems and strategies. Toxicology 233:23–30.
   PubMed Web of Science ®Google Scholar
• Worek, F., Aurbek, N., Thiermann, H. (2007). Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI-6 in vitro. J Appl Toxicol 27:582–588.
   PubMed Web of Science ®Google Scholar
• Worek, F., Diepold, C., Eyer, P. (1999). Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch Toxicol 73:7–14.
   PubMed Web of Science ®Google Scholar